Tower Research Capital LLC (TRC) - TETRAPHASE PHARMACEUTICALS I ownership

Back to all holdings Add to watchlist

TETRAPHASE PHARMACEUTICALS I's ticker is TTPH and the CUSIP is 88165N204. A total of 26 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2020$0
-100.0%
55
-91.5%
0.00%–
Q1 2020$1,000
-92.9%
645
-75.9%
0.00%
-100.0%
Q3 2019$14,000–2,672–0.00%–
 Download
Other shareholders

There were no reported owners of TETRAPHASE PHARMACEUTICALS I in Q2 2020.

NameSharesValueWeighting ↓
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders